Accéder au contenu
Merck

An optimized protocol for rapid, sensitive and robust on-bead ChIP-seq from primary cells.

STAR protocols (2021-03-16)
Lorane Texari, Nathanael J Spann, Ty D Troutman, Mashito Sakai, Jason S Seidman, Sven Heinz
RÉSUMÉ

Integrative analysis of next-generation sequencing data can help understand disease mechanisms. Specifically, ChIP-seq can illuminate where transcription regulators bind to regulate transcription. A major obstacle to performing this assay on primary cells is the low numbers obtained from tissues. The extensively validated ChIP-seq protocol presented here uses small volumes and single-pot on-bead library preparation to generate diverse high-quality ChIP-seq data. This protocol allows for medium-to-high-throughput ChIP-seq of low-abundance cells and can also be applied to other mammalian cells. For complete details on the use and execution of this protocol, please refer to Brigidi et al. (2019), Carlin et al. (2018), Heinz et al. (2018), Nott et al. (2019), Sakai et al. (2019), and Seidman et al. (2020).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
IGEPAL® CA-630, for molecular biology
Millipore
Unité de filtration Millex®-HP (stérile), pore size 0.45 μm, diam. 33 mm, polyethersulfone membrane, hydrophilic, medical device